Tuesday, October 23, 2012

Health - Google News: Bayer nails promising PhIII results for new PAH contender riociguat - FierceBiotech

Health - Google News
Google News
Bayer nails promising PhIII results for new PAH contender riociguat - FierceBiotech
Oct 22nd 2012, 12:03


Business Recorder

Bayer nails promising PhIII results for new PAH contender riociguat
FierceBiotech
Bayer is on a roll. Just days after nabbing a speedy FDA approval of its cancer drug Stivarga (regorafenib), Bayer says it has nailed positive Phase III data on its new drug for rare cases of pulmonary arterial hypertension, which sets up an NDA that leave ...
Bayer Drug Succeeds in Phase III PAH TrialGenetic Engineering News
Bayer lung drug shows promise in pulmonary hypertensionWHTC
Bayer's Riociguat Meets Primary Endpoint In Late Stage Study - Quick FactsNASDAQ

all 37 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 comments:

Post a Comment

Twitter Delicious Facebook Digg Stumbleupon Favorites More